Canopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics

Canopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics SMITHS FALLS, ON & LONDON, Oct. 15, 2019 /CNW/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or the “Company”) has closed the previously announced acquisition of all outstanding shares in the global cannabinoid based research company Beckley Canopy Therapeutics (Beckley Canopy), including … Continue reading Canopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics

Canopy Growth Announces Sale of Stake in AusCann

Canopy Growth Announces Sale of Stake in AusCann The companies will continue to collaborate in the Australian market SMITHS FALLS, ON, Oct. 15, 2019 /CNW/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth”) has sold its 42,087,639 shares in Australian cannabis company AusCann Group Holdings (AusCann) via an off market block trade at … Continue reading Canopy Growth Announces Sale of Stake in AusCann

Avicanna Commences Trading on the OTCQX Market in the United States

Avicanna Commences Trading on the OTCQX Market in the United States /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Oct. 15, 2019 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company”) (TSX: … Continue reading Avicanna Commences Trading on the OTCQX Market in the United States

Health Canada Leverages StrainprintR Technologies’ Real-Time Observational Data and Analytics to Better Understand Cannabis Use in Canada

Health Canada Leverages StrainprintR Technologies’ Real-Time Observational Data and Analytics to Better Understand Cannabis Use in Canada Strainprint Analytics Research Platform to Help Support Canadian Government Policies Post-Cannabis LegalizationF TORONTO (Oct. 15 2019) – StrainprintR Technologies Ltd. (Strainprint), the leader in cannabis data and analytics is proud to announce that Health Canada has subscribed to use Strainprint Analytics to further … Continue reading Health Canada Leverages StrainprintR Technologies’ Real-Time Observational Data and Analytics to Better Understand Cannabis Use in Canada

Vaping is not a safe substitute for smoking and can damage the lungs—a case study of granulomatosis resulting from vaping

Vaping is not a safe substitute for smoking and can damage the lungs—a case study of granulomatosis resulting from vaping NEW ORLEANS (Oct. 14, 2019)­­ Vaping is not a low-risk substitute for smoking cigarettes, according to researcher Charlie Lin, MD, who authored a case study of a 34-year-old former smoker diagnosed with granulomatosis attributed to … Continue reading Vaping is not a safe substitute for smoking and can damage the lungs—a case study of granulomatosis resulting from vaping